Recombinant Human IL17D Protein: Handling & Application Protocol
Recombinant Human IL17D Protein: Handling & Application Protocol
Recombinant Human IL17D Protein is a bioactive cytokine belonging to the IL-17 family, produced for use in cell-based assays, signaling studies, and immunological research requiring a well-characterized, reproducibly manufactured recombinant protein.
- Product Name
- Recombinant Human IL17D Protein
- SKU
- rp368342
- Protein Family
- IL-17 cytokine family
- Species Origin
- Human (Homo sapiens)
- Typical Application
- Cell-based assays, receptor binding studies, immunological research
- Storage Recommendation
- Avoid repeated freeze-thaw cycles; store at -20°C or -80°C upon receipt
Background: IL17D and the IL-17 Cytokine Family
Interleukin-17D (IL-17D) is a secreted cytokine and a member of the IL-17 family, which comprises six structurally related proteins (IL-17A through IL-17F). IL-17D signals through the IL-17 receptor complex and has been reported to modulate innate immune responses, promote the production of other cytokines such as IL-6, IL-8, and GM-CSF in endothelial and epithelial cells, and contribute to anti-tumor immune surveillance. Understanding the biology of IL-17D is relevant to research in inflammation, cancer immunology, and host defense mechanisms. Recombinant Human IL17D Protein (SKU: rp368342) provides a well-defined, consistent source of this cytokine for in vitro experimental use.
Materials and Equipment Required
- Recombinant Human IL17D Protein, lyophilized or liquid formulation (SKU: rp368342)
- Sterile, nuclease-free water or manufacturer-recommended reconstitution buffer (e.g., PBS containing 0.1% BSA)
- Sterile microcentrifuge tubes (1.5 mL)
- Calibrated micropipettes and sterile filter tips
- Refrigerated microcentrifuge
- Ice bucket or cooling block
- -20°C and/or -80°C freezer for long-term storage
- Cell culture reagents appropriate for your assay system
Note: Always consult the Certificate of Analysis (CoA) supplied with each lot for formulation-specific reconstitution instructions and confirmed activity data.
Step-by-Step Reconstitution and Storage Protocol
- Equilibrate to room temperature: Remove the vial from cold storage and allow it to equilibrate at room temperature for 10–15 minutes before opening to minimize condensation and protein aggregation.
- Brief centrifugation: Briefly centrifuge the sealed vial (1,000–2,000 × g, 30 seconds) to collect any lyophilized material from the walls and cap before reconstitution.
- Reconstitution: Add the recommended volume of sterile reconstitution buffer (typically sterile PBS with 0.1% BSA or as specified on the CoA) gently along the side of the vial. Do not inject directly onto the lyophilized cake.
- Gentle mixing: Gently swirl or rotate the vial for 1–2 minutes. Do not vortex, as vigorous agitation can denature the protein.
- Inspect the solution: Ensure the solution is clear and free of visible particulates. If particulates are present, centrifuge briefly at low speed.
- Aliquot immediately: Divide the reconstituted protein into single-use aliquots using sterile low-binding microcentrifuge tubes. This prevents repeated freeze-thaw cycles.
- Short-term storage: For use within 1–2 weeks, store aliquots at 4°C.
- Long-term storage: For longer storage, snap-freeze aliquots in liquid nitrogen or on dry ice and store at -80°C. Avoid repeated freeze-thaw cycles (maximum 2–3 cycles recommended).
Important: Specific storage conditions and shelf-life data are lot-dependent; always defer to the CoA provided with your shipment.
Application Guidelines and Working Concentrations
Recombinant Human IL17D Protein can be used in a variety of in vitro applications. Typical applications and suggested starting concentration ranges are listed below. Researchers should optimize concentrations empirically for their specific cell types and assay conditions.
- Cell stimulation assays: IL-17D has been reported to stimulate cytokine production (e.g., IL-6, IL-8) in endothelial and epithelial cell lines. A typical starting concentration range for cell stimulation is 10–100 ng/mL; titrate as needed.
- Receptor binding studies: Use the protein at concentrations appropriate for your binding assay format (ELISA-based binding, surface plasmon resonance, etc.); starting concentrations of 1–10 µg/mL are common for solid-phase binding assays.
- Reporter gene and signaling assays: Determine the effective concentration range by dose-response experiments, typically starting at 1 ng/mL and titrating up to 1,000 ng/mL.
Carrier protein consideration: When working at very low protein concentrations, include a carrier protein such as 0.1% BSA to minimize non-specific adsorption to tube and plate surfaces.
Endotoxin awareness: Confirm endotoxin levels from the CoA before use in sensitive cell-based assays, as endotoxin contamination can confound cytokine-stimulation results.
Troubleshooting Common Issues
| Issue | Possible Cause | Suggested Action |
|---|---|---|
| No or low biological activity | Protein denaturation due to improper reconstitution or freeze-thaw damage | Use fresh aliquot; ensure gentle reconstitution; avoid vortexing and repeated freeze-thaw |
| Visible aggregates or turbid solution | Protein aggregation from improper handling or incompatible buffer | Centrifuge at low speed; verify buffer composition; use recommended reconstitution buffer |
| High background in cell assay | Endotoxin contamination or non-specific carrier effects | Confirm endotoxin level from CoA; use LAL-tested, low-endotoxin BSA as carrier |
| Inconsistent results between experiments | Pipetting inaccuracy at low concentrations; adsorption to surfaces | Add carrier protein; use low-binding tubes and plates; pre-coat pipette tips |
Frequently asked questions
What is the recommended reconstitution buffer for Recombinant Human IL17D Protein?
The typical recommendation is sterile phosphate-buffered saline (PBS) supplemented with 0.1% bovine serum albumin (BSA). However, the exact buffer composition may vary by lot and formulation; always refer to the Certificate of Analysis (CoA) included with your specific shipment for confirmed instructions.
How should Recombinant Human IL17D Protein be stored to maintain activity?
Upon receipt, the protein should be stored at -20°C or -80°C for long-term stability. Aliquot the reconstituted protein into single-use volumes to avoid repeated freeze-thaw cycles, which can significantly reduce biological activity. For short-term use within one to two weeks, storage at 4°C is acceptable.
What cell types and assays is IL17D protein suitable for?
Recombinant Human IL17D Protein is suitable for use in cell stimulation assays with endothelial and epithelial cell lines to study cytokine induction (e.g., IL-6, IL-8, GM-CSF), receptor binding assays, and signaling pathway studies. Researchers should empirically determine the optimal working concentration for their specific experimental system.
How can I minimize non-specific adsorption when working at low concentrations?
To minimize non-specific adsorption, use low-binding microcentrifuge tubes and microplates, add a carrier protein such as 0.1% BSA to working solutions, and pre-coat pipette tips by aspirating and discarding a small volume of the protein solution before dispensing.
Is Recombinant Human IL17D Protein validated for in vivo use?
The product (SKU: rp368342) is intended for in vitro research use only. It is not validated, approved, or intended for use in clinical or in vivo therapeutic applications. Consult the product CoA and safety data sheet for confirmed application scope.
References
- Starnes T, et al. IL-17D, a novel member of the IL-17 family, stimulates cytokine and chemokine production and exhibits broad biological activities. Journal of Immunology. 2003.
- Gaffen SL. Structure and signalling in the IL-17 receptor family. Nature Reviews Immunology. 2009.
- Aladdin Scientific Certificate of Analysis, Recombinant Human IL17D Protein, SKU rp368342. (Lot-specific document supplied with product.)
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)